Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07793344
NA

Four-Week Ocular-Surface Evaluation of an Experimental Ophthalmic Liposomal Nanocarrier in Dry Eye Disease

Sponsor: Regional Specialist Hospital in Wroclaw

View on ClinicalTrials.gov

Summary

This prospective, single-group research medical experiment evaluated the ocular-surface response to repeated bilateral use of an experimental ophthalmic liposomal nanocarrier in adults with dry eye disease. Participants used one drop in each eye three times daily (morning, midday, and evening) for four weeks. Clinical assessments were performed at baseline and follow-up and included ocular-surface staining, tear-film stability, tear-volume measures, symptoms, and contextual ophthalmic measures. A nested optical assessment evaluated tear-film surface regularity and non-invasive tear-film parameters.

Official title: A Prospective Single-Group Research Medical Experiment Evaluating Four-Week Ocular-Surface and Tear-Film Response to an Experimental Ophthalmic Liposomal Nanocarrier in Adults With Dry Eye Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2022-03-17

Completion Date

2022-06-30

Last Updated

2026-08-28

Healthy Volunteers

No

Conditions

Interventions

OTHER

Experimental ophthalmic liposomal nanocarrier

One drop was instilled into each eye three times daily (morning, midday, and evening) for four weeks.

Locations (1)

Regional Specialist Hospital in Wroclaw

Wroclaw, Poland